Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Epidermal growth factor receptor may be marker of progression of penile squamous cancer

Feb. 25, 2011

BMS-936558 shows promise in RCC and mCRPC in phase I trial

Feb. 25, 2011

AR-42 displays potent antitumor effects in models of embryonal carcinoma

Feb. 25, 2011

Intraprostatic administration of PROSTVAC VF cancer vaccine is feasible and safe

Feb. 24, 2011

Interim phase I data support safety of tremelimumab plus bicalutamide in recurrent prostate cancer

Feb. 24, 2011

PSMA-ADC appears safe in first-in-human study in taxane-refractory metastatic CRPC

Feb. 24, 2011

Gelsolin is a putative biomarker in subarachnoid hemorrhage

Feb. 23, 2011

IST5-002 shows promise in models of prostate cancer

Feb. 23, 2011

Phase I/II trial of panobinostat/bicalutamide combination in prostate cancer advances

Feb. 23, 2011

Tasquinimod improves PFS in phase II trial in metastatic CRPC

Feb. 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...